Isracann Receives Project Characterization Report and Engages EU GMP Consultancy Cannabis Investing News
BriaCell Outlines New High Responding Patient Group ‘Biomarker’ Based on Cancer Grade Biotech Investing
FSD Pharma to Commence Trading on Nasdaq Capital Market Under Symbol ‘HUGE’ Cannabis Investing News
BriaCell Announces ESMO 2026 Poster Highlighting Circulating Immune Biomarker Associated with Clinical Outcomes in Metastatic Breast Cancer